Short-hairpin RNA-guided single gene knockdown reverses triple-negative breast cancer
Dong-Mei Chen, Zhu-Qing Shi, Li-Li Tan, Yan-Ping Chen, Chang-Qing Li, Qi Wang, He Li, Meng-Le Zhang, Jian-Ping Song, Qin Xu, Qing-Ping Zeng
Abstract
BackgroundThe origin of breast cancer remains poorly understood. Here, we testify a putative mechanism of \"breast cancer origin from inducible nitric oxide synthase (iNOS) activation and oestrogen receptor alpha (ER) inactivation\", which are classified as the essential outcomes of chronic inflammatory responses.\n\nMethodsTo reverse breast cancer status, iNOS was downregulated by short-hairpin RNA (shRNA)-guided NOS2 knockdown from human triple-negative breast cancer (TNBC) cells. To re-enact breast cancer origin, ER was downregulated by shRNA-directed ESR1 knockdown in human mammary epithelial cells.\n\nResultsUpon NOS2 knockdown from HCC1937 cells, the specific TNBC transcription factor genes, RUNX1 and BCL11A, were downregulated, hypoxia was compromised, Warburg effects were attenuated, and tumourigenic proliferation was halted, accompanied by an increase in the tumour marker cyclin D1 (CD1) and a decrease in the tumour suppressor cyclin-dependent kinase inhibitor (CKI). In contrast, ESR1 knockdown from MCF-10A cells led to upregulated BCL11A and RUNX1 expression, augmented hypoxic responses, pronounced Warburg effects, and enhanced PI3K/Akt/mTOR signalling, together with low levels of CD1 and high levels of CKI induction.\n\nConclusionsBreast cancer should originate from inflammatory signalling, during which iNOS activation and ER inactivation elicit hypoxia, oxidation, mitochondrial dysfunction, and breast cancer-like hyperplasia, demonstrating that iNOS inhibitors and ER activators represent promising candidate prodrugs enabling breast cancer prevention in the early stage.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Notch1 regulates breast cancer stem cell function via a non-canonical cleavage-independent pathway
L. Sui, S. Wang, … R. S. Watnick·bioRxiv·Feb 28, 2020
- Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB mediated inflammatory response in Triple Negative Breast Cancer
Elizabeth F. Sher, Kenji Mark Fujihara, … Richard Possemato·bioRxiv·Sep 18, 2025
- CDK19 is a Regulator of Triple-Negative Breast Cancer Growth
Robert W. Hsieh, Angera H. Kuo, … Michael F. Clarke·bioRxiv·May 10, 2018
- Enrichment of breast cancer stem cells following cytotoxic chemotherapy is mediated by hypoxia-inducible factors
D. Samanta, D. M. Gilkes, … G. L. Semenza·bioRxiv·Jun 27, 2022
- Silencing of the CSNK2β gene by siRNA inhibits invasiveness and growth of MDA-MB-231 cells
Shibendra Kumar Lal Karna, Bilal Ahmad Lone, … Yuba Raj Pokharel·bioRxiv·Apr 30, 2018
- MNRR1 is required for Triple Negative Breast Cancer growth and metastasis and can be targeted by repurposed drugs.
Mrunal Sathe, Paige M. Minchella, … Siddhesh Aras·bioRxiv·Feb 3, 2026